About us

PROOF OF CONCEPT TRIALS

proof of concept trials

ARENSIA delivers high degree of scientific and logistical expertise for Phase I/Ib/IIa and PROOF OF CONCEPT patient studies.

MORE

PHASE I SPECIAL POPULATIONS

phase i special populations

ARENSIA offers exceptional fast recruitment rates for renal and hepatic impaired patients.

MORE

REGULATORY PROCESS

regulatory process

ARENSIA has the know-how to successfully manage the regulatory process in various Eastern European countries.

MORE

ABOUT ARENSIA

ARENSIA Exploratory Medicine is a German clinical research company, with head offices in Düsseldorf, specialized to address a strategic market niche, namely the high need for FAST PATIENT RECRUITMENT in Phase I / II / PROOF OF CONCEPT clinical trials.

ARENSIA has built up its own network of state-of-the-art Exploratory Medicine Units, with full Phase I infrastructure, located across prestigious University Hospitals in Eastern Europe – Romania, Moldova, Georgia and Ukraine. The units are dedicated to perform sophisticated exploratory protocols with novel compounds – incl. intensive PK and PD profiles, long hospitalization, latest imaging technology – and involving patients across numerous disease areas.

ARENSIA is committed to enable patients the access to new therapies as early as possible. Patient´s safety and comfort are of paramount priority at all ARENSIA research units.

ARENSIA has repeat business with the major international Sponsors.

Working with ARENSIA leads to increased efficiency by shortening recruitment time while the number of involved sites/countries can be reduced. This translates into considerable cost savings for the SPONSOR at overall project level.